Publicação
Influence of the Glidant on Diluent Flow Characterization Using Shear Cell Method
| dc.contributor.author | Salústio, Paulo J. | |
| dc.contributor.author | Machado, Mafalda | |
| dc.contributor.author | Nunes, Telmo | |
| dc.contributor.author | Sousa e Silva, José Paulo | |
| dc.contributor.author | Costa, Paulo Cardoso | |
| dc.date.accessioned | 2022-08-09T18:20:35Z | |
| dc.date.available | 2022-08-09T18:20:35Z | |
| dc.date.issued | 2022 | |
| dc.date.updated | 2022-06-29T14:46:13Z | |
| dc.description.abstract | The aim of this study was to compare the bulk lactose flow behavior with a defined fraction with smaller particles obtained by sieving from the bulk lactose and to evaluate the effect of a glidant addition on both samples. These powders showed, in a previous work, similar flow indexes (ffc) that motivated the addition of colloidal silicon dioxide in order to observe if there were any changes in their flow behaviors. Methods To evaluate this effect on the diluent flow behavior, the methods described in the European Pharmacopeia were used. Results The results obtained from conventional methods and shear cell methods (using the Powder Flow Tester) were compared, and they showed evident differences in the bulk and tapped densities values and flow classifications. The lactose monohydrate (FTotal) and lactose with particles smaller than 63 μm (F < 63) analyzed in a previous study presented similar ffc. To these pure powders a glidant was added, in increasing proportion (0.25—1.00%). The results obtained for all powders with colloidal silicon dioxide showed an improvement in its flow behaviors in comparison with pure powders. Conclusion All the parameters studied showed an evident effect of the glidant used. For the same amount of glidant, the F < 63 presented worse flow profiles than FTotal because its particles have a larger surface area. The FTotal + 0.25 flow profile was more similar to the F < 63 + 0.50 flow profile than F < 63 + 0.25 flow profile. For both powders, the maximum amount of glidant that produces effect was 1.00% for F < 63 and 0.75% for FTotal, respectively. In all powders, the occurrence of caking was not observed. | pt_PT |
| dc.description.sponsorship | The authors would like to thank Dra. Teresa Malta and Atral, S.A., for the kindly supplying of the lactose monohydrate, that made this work possible. This work was supported by the Applied Molecular Biosciences Unit-UCIBIO, which is financed by national funds from FCT/MCTES (UID/Multi/04378/2019). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Salústio PJ, Machado M, Nunes T, Sousa e Silva JP, Costa PC. Influence of the Glidant on Diluent Flow Characterization Using Shear Cell Method. J Pharm Innov 2022;17:60–70. https://doi.org/10.1007/s12247-020-09478-6. | pt_PT |
| dc.identifier.doi | 10.1007/s12247-020-09478-6 | pt_PT |
| dc.identifier.issn | 1872-5120 | |
| dc.identifier.issn | 1939-8042 | |
| dc.identifier.slug | cv-prod-3015147 | |
| dc.identifier.uri | http://hdl.handle.net/10451/54098 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Springer Nature | pt_PT |
| dc.relation | Applied Molecular Biosciences Unit | |
| dc.relation.publisherversion | https://link.springer.com/article/10.1007/s12247-020-09478-6 | pt_PT |
| dc.subject | Flow index | pt_PT |
| dc.subject | Flowing | pt_PT |
| dc.subject | Shear cell | pt_PT |
| dc.subject | Diluent | pt_PT |
| dc.subject | Glidant | pt_PT |
| dc.title | Influence of the Glidant on Diluent Flow Characterization Using Shear Cell Method | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardNumber | UID/Multi/04378/2019 | |
| oaire.awardTitle | Applied Molecular Biosciences Unit | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FMulti%2F04378%2F2019/PT | |
| oaire.citation.endPage | 70 | pt_PT |
| oaire.citation.issue | 1 | pt_PT |
| oaire.citation.startPage | 60 | pt_PT |
| oaire.citation.title | Journal of Pharmaceutical Innovation | pt_PT |
| oaire.citation.volume | 17 | pt_PT |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| person.familyName | Salústio | |
| person.givenName | Paulo | |
| person.identifier.ciencia-id | 7012-1477-468E | |
| person.identifier.orcid | 0000-0001-8792-5994 | |
| person.identifier.scopus-author-id | 25646145600 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.cv.cienciaid | 7012-1477-468E | Paulo José Pinto Salústio | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | ba921c3c-175f-480b-afb4-c47e23f73560 | |
| relation.isAuthorOfPublication.latestForDiscovery | ba921c3c-175f-480b-afb4-c47e23f73560 | |
| relation.isProjectOfPublication | 8325b928-9908-40e3-b06a-c4cd3d6adede | |
| relation.isProjectOfPublication.latestForDiscovery | 8325b928-9908-40e3-b06a-c4cd3d6adede |